GB202005593D0 - New composition - Google Patents

New composition

Info

Publication number
GB202005593D0
GB202005593D0 GBGB2005593.5A GB202005593A GB202005593D0 GB 202005593 D0 GB202005593 D0 GB 202005593D0 GB 202005593 A GB202005593 A GB 202005593A GB 202005593 D0 GB202005593 D0 GB 202005593D0
Authority
GB
United Kingdom
Prior art keywords
new composition
composition
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2005593.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanexa AB
Original Assignee
Nanexa AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanexa AB filed Critical Nanexa AB
Priority to GBGB2005593.5A priority Critical patent/GB202005593D0/en
Publication of GB202005593D0 publication Critical patent/GB202005593D0/en
Priority to CA3179556A priority patent/CA3179556A1/en
Priority to JP2022562978A priority patent/JP7883442B2/ja
Priority to EP21721971.6A priority patent/EP4135672A1/en
Priority to US17/919,415 priority patent/US20230157968A1/en
Priority to KR1020227038860A priority patent/KR20230004568A/ko
Priority to AU2021256075A priority patent/AU2021256075A1/en
Priority to CN202180041014.6A priority patent/CN116075295A/zh
Priority to PCT/GB2021/050913 priority patent/WO2021209762A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB2005593.5A 2020-04-17 2020-04-17 New composition Ceased GB202005593D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB2005593.5A GB202005593D0 (en) 2020-04-17 2020-04-17 New composition
CA3179556A CA3179556A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition
JP2022562978A JP7883442B2 (ja) 2020-04-17 2021-04-16 新しい注射用油性医薬組成物
EP21721971.6A EP4135672A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition
US17/919,415 US20230157968A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition
KR1020227038860A KR20230004568A (ko) 2020-04-17 2021-04-16 주사 가능한 유성 약제학적 조성물
AU2021256075A AU2021256075A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition
CN202180041014.6A CN116075295A (zh) 2020-04-17 2021-04-16 新型可注射油基药物组合物
PCT/GB2021/050913 WO2021209762A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2005593.5A GB202005593D0 (en) 2020-04-17 2020-04-17 New composition

Publications (1)

Publication Number Publication Date
GB202005593D0 true GB202005593D0 (en) 2020-06-03

Family

ID=70860026

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2005593.5A Ceased GB202005593D0 (en) 2020-04-17 2020-04-17 New composition

Country Status (9)

Country Link
US (1) US20230157968A1 (cg-RX-API-DMAC10.html)
EP (1) EP4135672A1 (cg-RX-API-DMAC10.html)
JP (1) JP7883442B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230004568A (cg-RX-API-DMAC10.html)
CN (1) CN116075295A (cg-RX-API-DMAC10.html)
AU (1) AU2021256075A1 (cg-RX-API-DMAC10.html)
CA (1) CA3179556A1 (cg-RX-API-DMAC10.html)
GB (1) GB202005593D0 (cg-RX-API-DMAC10.html)
WO (1) WO2021209762A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023105227A1 (en) * 2021-12-08 2023-06-15 Nanexa Ab New injectable combination formulation
GB2619556A (en) * 2022-06-10 2023-12-13 Nanexa Ab New process
AU2023392764A1 (en) * 2022-12-15 2025-06-19 Nanexa Ab New pharmaceutical compositions comprising glucagon-like peptide-1 receptor agonists
GB202218958D0 (en) 2022-12-15 2023-02-01 Nanexa Ab New pharmaceutical composition
CN117844877B (zh) * 2024-01-14 2024-09-06 宿州市东凯医药科技有限公司 一种通过生物酶制备普瑞巴林的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097742B2 (en) 2005-01-20 2012-01-17 Agency For Science, Technology And Research Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
EP3685837A1 (en) * 2008-09-04 2020-07-29 Amylin Pharmaceuticals, LLC Sustained release formulations using non-aqueous carriers
KR102264011B1 (ko) 2013-05-24 2021-06-10 나넥사 에이비 무기성 코팅을 갖는 고형의 나노입자

Also Published As

Publication number Publication date
WO2021209762A1 (en) 2021-10-21
US20230157968A1 (en) 2023-05-25
JP7883442B2 (ja) 2026-07-01
JP2023522056A (ja) 2023-05-26
KR20230004568A (ko) 2023-01-06
CA3179556A1 (en) 2021-10-21
AU2021256075A1 (en) 2022-11-03
CN116075295A (zh) 2023-05-05
EP4135672A1 (en) 2023-02-22

Similar Documents

Publication Publication Date Title
EP4256011C0 (en) COMPOSITION
GB202005911D0 (en) Composition
GB202006074D0 (en) New composition
GB202006079D0 (en) New composition
GB202004460D0 (en) Herbical composition
GB202103439D0 (en) Composition
GB202018029D0 (en) Composition
GB202012895D0 (en) Composition
GB202007377D0 (en) Composition
GB202016236D0 (en) Composition
GB202006081D0 (en) New composition
GB202006093D0 (en) Composition
EP4259762C0 (en) COMPOSITION
GB202103434D0 (en) Composition
GB202000619D0 (en) Composition
EP4330363C0 (en) COMPOSITION
GB202005586D0 (en) New composition
GB202104498D0 (en) Composition
GB202014635D0 (en) Composition
GB202003550D0 (en) Composition
GB202117701D0 (en) New composition
GB202117703D0 (en) New composition
GB202108297D0 (en) New composition
GB202108282D0 (en) New composition
GB202007043D0 (en) New composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)